The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
Update on 2010 EULAR RA Guidelines Now in Print
February 13th 2014Updated EULAR guidelines on treatment of rheumatoid arthritis, now published in the society's journal, advocate combination treatment, state reservations about tofacitinib, and declare a new preference for glucocorticoids in all combinations while withdrawing a preference for TNF inhibitors as second-line therapy.
Tracking the Trickster, Or: The Confounding Tale of IgG4RD (Chapter II)
February 11th 2014In Chapter I, you read the history and baffling description of IgG4-Related Disease, which goes by so many disguises, and learned of its previously known whereabouts. Herein, you have the opportunity to track it by solving a series of challenges.
Tracking the Trickster, Or: The Confounding Tale of IgG4-RD (Chapter I)
February 5th 2014IgG4-Related Disease (IgG4-RD): one of the most perplexing culprits ever to defy a rheumatologist. Here, we present a few basics about its shadowy past and its current known identity. Later Chapters in our series will invite you to track the diagnosis yourself and to discover the best treatment strategies.
Blood Pressure Drug Improves Functional Status of Peripheral Artery Disease Patients
February 5th 2014Among patients with peripheral artery disease and intermittent claudication, a daily dose of 10 mg ramipril can improve pain-free treadmill walking times, which are associated with a significant increase in physical functioning.
Risk Factors for Cutaneous-to-Systemic Lupus Progression Identified
February 3rd 2014A retrospective review establishes that progression from cutaneous lupus to SLE is infrequent, and identifies factors common among those in whom the disease does progress. Also, a study from Scotland questions whether dermatologists are too busy to follow guidelines for management of psoriatic arthritis.
Distinguishing Orthopedic Deformities in Kids
January 31st 2014Among its comprehensive review articles on spinal deformities, fractures, and other pediatric orthopedic conditions, the December 2013 issue of Surgery includes a concise and interesting article on the many foot problems orthopedic surgeons may encounter in children.
"Rheumatoid Disease" Advocates Offer New Name, New Focus on RA
January 31st 2014Sunday, February 2, has been designated the second annual "Rheumatoid Awareness Day" by a new foundation determined to rename RA as "Rheumatoid Disease." Their research shows that many people don't distinguish RA from OA, and has also found new kinds of disability of which even rheumatologists were unaware.
OARSI Issues New Guidelines for Knee OA
January 31st 2014The Osteoarthritis Research Society International has given NSAIDs, corticosteroid injections, and canes the nod as appropriate for knee OA. Other interventions, including glucosamine/chondroitin and intra-articular hyaluronic acid, are judged of uncertain benefit.
New FDA Review Calls Naproxen Safe for CV System
January 30th 2014The FDA Advisory Committee responsible for arthritis drugs is considering recent evidence that shows naproxen not to be associated with increased cardiovascular risk, unlike other painkillers in its class. Their recommendations may lead to suspension of a comparative clinical trial and to label changes.
36-Year-Old Woman With Raynaud, Facial Paresthesia, and Rash
January 29th 2014A kidney biopsy is ordered after a 36-year-old woman initially diagnosed with isolated Raynaud phenomenon reports a series of new symptoms: arthralgia, facial paresthesia, then a photosenstive rash. The problem may not match your first guess.